NewsRx

Search our medical news database

Glaucoma

Milestone achieved as Allergan advances glaucoma drug candidate

Published in Medical Devices and Surgical Technology Week, February 8th, 2004

Acadia Pharmaceuticals announced that it has achieved a milestone in its collaboration agreement with Allergan (AGN) to discover, develop, and commercialize selective muscarinic drugs for the treatment of glaucoma.

The milestone was triggered by Allergan's selection of a collaboration compound for further development and commercialization.

"We are pleased to successfully achieve this phase of our collaboration with Acadia, which has generated an exciting new class of novel and selective muscarinic compounds," said Lester J. Kaplan, PhD, Allergan's president, research and development. "These drug candidates display a promising preclinical profile and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook